[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX161397A - Procedimiento para preparar derivados de 1,3 oxazolidin-2-ona - Google Patents

Procedimiento para preparar derivados de 1,3 oxazolidin-2-ona

Info

Publication number
MX161397A
MX161397A MX205493A MX20549385A MX161397A MX 161397 A MX161397 A MX 161397A MX 205493 A MX205493 A MX 205493A MX 20549385 A MX20549385 A MX 20549385A MX 161397 A MX161397 A MX 161397A
Authority
MX
Mexico
Prior art keywords
oxazolidin
ona
procedure
preparing derivatives
derivatives
Prior art date
Application number
MX205493A
Other languages
English (en)
Inventor
Mitsuo Masaki
Haruhiko Shinozaki
Masuru Satoh
Original Assignee
Nippon Chemiphar Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co filed Critical Nippon Chemiphar Co
Publication of MX161397A publication Critical patent/MX161397A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/22Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX205493A 1984-09-28 1985-05-31 Procedimiento para preparar derivados de 1,3 oxazolidin-2-ona MX161397A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59203624A JPS6183170A (ja) 1984-09-28 1984-09-28 新規な1,3−オキサゾリジン−2−オン誘導体およびその製造法

Publications (1)

Publication Number Publication Date
MX161397A true MX161397A (es) 1990-09-20

Family

ID=16477122

Family Applications (2)

Application Number Title Priority Date Filing Date
MX205493A MX161397A (es) 1984-09-28 1985-05-31 Procedimiento para preparar derivados de 1,3 oxazolidin-2-ona
MX2159290A MX21592A (es) 1984-09-28 1990-07-16 1,3-oxazolidin-2-ona.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2159290A MX21592A (es) 1984-09-28 1990-07-16 1,3-oxazolidin-2-ona.

Country Status (27)

Country Link
US (1) US4644063A (es)
JP (1) JPS6183170A (es)
KR (1) KR900004323B1 (es)
AR (1) AR240924A1 (es)
AT (1) AT392069B (es)
AU (1) AU566419B2 (es)
BR (1) BR8502707A (es)
CA (1) CA1252092A (es)
CH (1) CH663207A5 (es)
CS (1) CS273606B2 (es)
DE (1) DE3519261C2 (es)
DK (1) DK165952C (es)
ES (2) ES8800571A1 (es)
FR (1) FR2571052B1 (es)
GB (2) GB8512975D0 (es)
HU (1) HU199132B (es)
IN (1) IN162060B (es)
IT (1) IT1208807B (es)
MX (2) MX161397A (es)
MY (1) MY102081A (es)
NL (1) NL193191C (es)
NZ (1) NZ212143A (es)
PH (1) PH20852A (es)
RO (1) RO91422B (es)
SE (1) SE463100B (es)
SU (2) SU1402263A3 (es)
ZA (1) ZA854001B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6183147A (ja) * 1984-09-28 1986-04-26 Nippon Chemiphar Co Ltd 新規なアミノアルコール誘導体およびその製造法並びにそれを有効成分とするグルタミン酸遮断剤
JPH0759570B2 (ja) * 1986-05-06 1995-06-28 三井東圧化学株式会社 2−オキサゾリジノン類の製造方法
JPH0713017B2 (ja) * 1986-06-18 1995-02-15 日本ケミファ株式会社 脳細胞保護作用を有する医薬組成物
ES2053748T3 (es) * 1987-09-10 1994-08-01 Merck Sharp & Dohme Oxazoles y tiazoles para el tratamiento de la demencia senil.
CA1329128C (en) * 1988-03-24 1994-05-03 Nobuyoshi Iwata Isoxazolinones as cerebro-active drugs
JPH0314562A (ja) * 1988-04-11 1991-01-23 Nippon Chemiphar Co Ltd 新規なアルキレンジアミン誘導体およびグルタミン酸遮断剤
US5187171A (en) * 1989-01-09 1993-02-16 G. D. Searle & Co. Use of a glycine b partial agonist as an antipsychotic
ES2121036T3 (es) * 1992-07-14 1998-11-16 Nippon Chemiphar Co Derivados de alquilenodiamina.
US5698573A (en) * 1993-09-15 1997-12-16 Merck, Sharp & Dohme, Ltd. Imidazolone and oxazolone derivatives as dopamine antagonists
DE4425613A1 (de) * 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
US6037354A (en) 1997-06-18 2000-03-14 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
AU2014230940B2 (en) 2013-03-14 2016-12-08 Akzo Nobel Chemicals International B.V. Cellulose ether as a drift control agent and rainfastness agent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2437389A (en) * 1948-03-09 Oxazoeidones and erocesstok
DE1135461B (de) * 1959-05-08 1962-08-30 Knoll Ag Verfahren zur Herstellung von basisch substituierten Phthalimidinen
FR1301267A (fr) * 1961-04-04 1962-08-17 Science Union Et Compagnie Soc Nouveaux dérivés de l'oxazolidinone-2 et leurs procédés de préparation
US3131197A (en) * 1963-03-13 1964-04-28 Smith Kline French Lab 5-(3, 4-carbonyldioxyphenyl)-3-isopropyl-2-oxazolidone
US3576808A (en) * 1967-09-15 1971-04-27 Miles Lab N-4-phenyl-1-piperazinylalkyl-5-phenyl-oxazolidinones
GB1222708A (en) * 1968-10-22 1971-02-17 Delalande Sa Novel 5-(n-substituted aminomethyl)-2-oxazolidinones and their process of preparation
FR2179582B1 (es) * 1972-04-13 1975-10-10 Synthelabo

Also Published As

Publication number Publication date
GB8512975D0 (en) 1985-06-26
AU4469785A (en) 1986-04-10
AR240924A2 (es) 1991-03-27
ZA854001B (en) 1986-01-29
ES8802152A1 (es) 1988-04-01
IT1208807B (it) 1989-07-10
IN162060B (es) 1988-03-19
HU199132B (en) 1990-01-29
AR240924A1 (es) 1991-03-27
KR900004323B1 (ko) 1990-06-22
NL193191B (nl) 1998-10-01
SE8502525D0 (sv) 1985-05-22
ES557075A0 (es) 1988-04-01
GB2165237A (en) 1986-04-09
NL8501579A (nl) 1986-04-16
ATA165685A (de) 1990-07-15
MY102081A (en) 1992-03-31
SU1402263A3 (ru) 1988-06-07
CA1252092A (en) 1989-04-04
DK165952B (da) 1993-02-15
PH20852A (en) 1987-05-19
ES8800571A1 (es) 1987-11-01
AU566419B2 (en) 1987-10-22
AT392069B (de) 1991-01-25
SU1431679A3 (ru) 1988-10-15
FR2571052B1 (fr) 1988-03-04
DK165952C (da) 1993-07-05
RO91422A (ro) 1987-06-30
BR8502707A (pt) 1986-05-27
FR2571052A1 (fr) 1986-04-04
GB2165237B (en) 1987-12-09
GB8513685D0 (en) 1985-07-03
SE463100B (sv) 1990-10-08
CS392785A2 (en) 1990-08-14
ES543517A0 (es) 1987-11-01
DK230185A (da) 1986-03-29
HUT39168A (en) 1986-08-28
NL193191C (nl) 1999-02-02
SE8502525L (sv) 1986-03-29
DE3519261A1 (de) 1986-04-10
DK230185D0 (da) 1985-05-23
KR860002502A (ko) 1986-04-26
US4644063A (en) 1987-02-17
MX21592A (es) 1994-01-31
RO91422B (ro) 1987-07-02
IT8567500A0 (it) 1985-05-30
JPH0469150B2 (es) 1992-11-05
JPS6183170A (ja) 1986-04-26
NZ212143A (en) 1987-11-27
CH663207A5 (fr) 1987-11-30
DE3519261C2 (de) 1997-01-16
CS273606B2 (en) 1991-03-12

Similar Documents

Publication Publication Date Title
MX159807A (es) Procedimiento para preparar derivados de bencimidazol
MX7199E (es) Procedimiento para preparar derivados de 3-cetodelta-4,9,19-nor-esteroides
ES543186A0 (es) Procedimiento para preparar nuevos derivados de aminotetra- lina
ES546484A0 (es) Procedimiento para la preparacion de derivados de furazano
ES540464A0 (es) Procedimiento para preparar derivados de pleuromutilina
ES540080A0 (es) Procedimiento de preparar nuevos derivados de 1,3-dihidro-6-(1-hidroxi-2-dimetilaminometil-alil)-7-hidroxi-furo-(3,4-c)-piridina
MX161397A (es) Procedimiento para preparar derivados de 1,3 oxazolidin-2-ona
MX159654A (es) Procedimiento para preparar derivados de hidroxi-4-2h-1-benzotiopiran-2-onas
ES550960A0 (es) Procedimiento para preparar derivados azolialquilicos
ES557370A0 (es) Procedimiento para preparar derivados de (dihidro-4,5-1h-imidazolil-2)-dihidro-2,3-indol
ES530574A0 (es) Procedimiento para preparar derivados de pirazol 1,5-a-piridina
ES543985A0 (es) Procedimiento para preparar derivados de butiramida
ES546908A0 (es) Procedimiento para la preparacion de derivados de fenilace- tonitrilo
ES557423A0 (es) Procedimiento para la preparacion de derivados de 1,4-dihidropiridina
ES555459A0 (es) Procedimiento para preparar derivados de saframicina a.
ES546802A0 (es) Procedimiento para preparar derivados de 7-oxo-4-tia-1-aza- biciclo(3,2,0)hept-2-eno
ES549076A0 (es) Procedimiento para preparar derivados de fenilpiperazina
ES547090A0 (es) Procedimiento para preparar derivados de benzazol
ES554828A0 (es) Procedimiento para preparar derivados de fluoralcanos.
MX159632A (es) Procedimiento para la preparacion de derivados de pirimidina 2,4,6,triona
MX156795A (es) Procedimiento para preparar derivados de 4,5,6,7-tetrahidrofuro-(2,3-c)-piridina
ES554603A0 (es) Procedimiento para preparar derivados de 3, 4-diazol
ES541140A0 (es) Procedimiento para preparar derivados carboxialquildipepti- dicos
ES549906A0 (es) Procedimiento para la preparacion de derivados de 1,4-dihi- dropiridina
ES543014A0 (es) Procedimiento para preparar nuevos derivados de quinoleina